+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Health Active Pharmaceutical Ingredients Market - Global Forecast 2026-2032- Product Image
Animal Health Active Pharmaceutical Ingredients Market - Global Forecast 2026-2032- Product Image
Sale

Animal Health Active Pharmaceutical Ingredients Market - Global Forecast 2026-2032

  • Report

  • 186 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5367879
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Health Active Pharmaceutical Ingredients Market is projected to reach USD 10.87 Billion in 2026. It is expected to continue growing at a CAGR of 6.30%, reaching USD 15.73 Billion by 2032.

The animal health active pharmaceutical ingredients market sits at the intersection of livestock productivity, companion animal care, food security, and antimicrobial stewardship. Demand is anchored by APIs used in antiparasitics, anti-infectives, anti-inflammatory therapies, anesthetics, sedatives, coccidiostats, endectocides, and reproductive health products for cattle, swine, poultry, aquaculture, horses, and companion animals.

Signals from WOAH, FAO, WHO, FDA, EMA, USDA, Health Canada, the European Commission, and national veterinary authorities show that growth is no longer defined by volume alone. Buyers increasingly prioritize GMP-grade manufacturing, residue-limit compliance, impurity control, pharmacovigilance readiness, traceable sourcing, environmental responsibility, and continuity of supply as animal disease pressure, protein consumption, pet humanization, and responsible-use regulations reshape purchasing decisions.

Transformative Shifts Reshaping Animal Health Active Pharmaceutical Ingredients

The animal health active pharmaceutical ingredients landscape is being reshaped by tighter veterinary medicine regulation, stronger antimicrobial stewardship, and higher expectations for product quality. In the United States, FDA Guidance for Industry #263 brought remaining over-the-counter medically important antimicrobials for animals under veterinary oversight in 2023. In Europe, Regulation (EU) 2019/6 and related medicated feed rules strengthened controls on veterinary medicines, prophylactic use, and antimicrobial resistance risk management, while Codex and national residue frameworks continue to influence global trade.

At the same time, manufacturers are redesigning supply networks to reduce dependence on single-source intermediates, improve audit readiness, and secure access to critical molecules. China and India remain central to API and intermediate production, while North America, Europe, Japan, South Korea, and Australia emphasize validated quality systems, biosecurity, data integrity, and regulatory documentation. These shifts favor suppliers with scalable synthesis, fermentation expertise, environmental controls, quality-by-design practices, and transparent documentation across the veterinary pharmaceutical value chain.

Cumulative Impact of Artificial Intelligence on Animal Health APIs

Artificial intelligence is creating cumulative value across animal health API discovery, development, manufacturing, and commercialization. AI-enabled cheminformatics, QSAR modeling, molecular docking, and ADME-toxicity prediction help screen candidate compounds faster, while machine learning supports antimicrobial resistance surveillance, pharmacovigilance signal detection, literature monitoring, and species-specific dose optimization when paired with validated biological, residue, and clinical data.

In manufacturing, AI can improve process analytical technology, deviation detection, predictive maintenance, batch-yield optimization, inventory planning, and demand forecasting. Its impact is strongest when deployed within GxP-compliant data governance, validated model controls, cybersecurity safeguards, and human scientific review. For animal health API producers, AI is becoming a competitive layer that improves resilience, reduces waste, supports quality assurance, and accelerates evidence generation without replacing regulatory proof, stability data, residue studies, or veterinary safety assessment.

Key Regional Insights for Animal Health API Demand

Asia-Pacific is both a major production base and a high-priority consumption region for animal health active pharmaceutical ingredients, supported by China and India in API and intermediate manufacturing and by Japan, South Korea, and Australia in high-standard veterinary care, biosecurity, and quality expectations. FAO data confirm the region’s major role in livestock, poultry, aquaculture, and companion animal populations, while national policies on food safety and antimicrobial use continue to shape demand for antiparasitic, anti-inflammatory, reproductive, and therapeutic APIs.

North America remains a premium region shaped by veterinary oversight, companion animal spending, livestock biosecurity, FDA Center for Veterinary Medicine requirements, Health Canada regulation, and residue-compliance expectations. Europe is defined by stringent antimicrobial stewardship, EMA guidance, European Commission veterinary medicine rules, pharmacovigilance obligations, and harmonized residue controls. Latin America, led by Brazil and Mexico, benefits from large cattle, poultry, and swine industries and strong participation in animal protein trade, increasing the need for dependable antiparasitic and disease-management APIs. The Middle East, particularly GCC economies, relies on imports tied to food security programs, intensive farming, and equine health, while Africa presents long-term demand linked to infectious disease control, parasitic disease management, poultry expansion, pastoral livestock systems, and access to affordable quality-assured veterinary medicines.

Key Group Insights Shaping Regulatory and Trade Dynamics

ASEAN markets are gaining importance as poultry, aquaculture, dairy, and companion animal care expand alongside regional manufacturing ambitions and improving veterinary regulation. The GCC is shaped by import dependence, food security strategies, desert-climate livestock management, intensive farming, and demand for quality-assured veterinary medicines suitable for poultry, ruminants, and equine care. The European Union continues to set influential benchmarks through harmonized veterinary medicine legislation, residue controls, pharmacovigilance, environmental assessment, and antimicrobial stewardship requirements.

BRICS economies combine large livestock populations, manufacturing scale, rising domestic veterinary demand, and strategic relevance in animal protein supply, with China and India central to API production and Brazil highly relevant to cattle and poultry exports. G7 markets emphasize innovation, regulatory rigor, data integrity, companion animal therapeutics, pharmacovigilance systems, and validated manufacturing. NATO is not a veterinary trade bloc, but many of its member economies increasingly link health security, supply chain resilience, biosecurity, critical medicine availability, and preparedness planning, which indirectly elevates the importance of reliable animal health API supply.

Key Country Insights for High-Value Animal Health API Markets

The United States is driven by FDA veterinary oversight, veterinary feed directive controls, large companion animal expenditure, and intensive cattle, swine, poultry, and aquaculture production. Canada emphasizes regulated access, food safety, antimicrobial stewardship, and residue control, while Mexico combines growing domestic animal protein demand with integration into North American trade and expanding veterinary distribution. Brazil is a global livestock and poultry powerhouse, creating sustained demand for antiparasitic, anti-infective, anti-inflammatory, reproductive, and productivity-supporting APIs under increasingly quality-focused procurement conditions.

The United Kingdom, Germany, France, Italy, and Spain operate under mature veterinary medicine systems with strong emphasis on antimicrobial stewardship, pharmacovigilance, residue compliance, and companion animal care. Russia remains relevant through large livestock needs, domestic production priorities, and import-substitution policies. China and India are pivotal for API production capacity, intermediates, fermentation and synthesis capabilities, and domestic veterinary demand, while Japan, Australia, and South Korea represent high-quality markets with advanced regulatory expectations, strong companion animal care, strict biosecurity cultures, and rigorous food-safety controls for livestock and aquaculture products.

Actionable Recommendations for Animal Health API Leaders

Industry leaders should prioritize resilient sourcing, validated quality systems, and regulatory-ready documentation for critical animal health APIs. Dual sourcing of intermediates, supplier qualification, impurity profiling, nitrosamine and genotoxic impurity risk assessment where applicable, environmental compliance, data integrity, and stability-data discipline are essential as buyers reduce exposure to supply disruption and regulatory non-compliance.

Companies should also align portfolios with responsible antimicrobial use, parasitic disease control, companion animal therapeutics, livestock biosecurity, and aquaculture health. Investment in AI-supported R&D, process optimization, pharmacovigilance analytics, antimicrobial resistance monitoring, and demand forecasting can improve speed, quality, and cost control. Commercial teams should localize strategies by species mix, disease burden, residue-limit requirements, veterinary channel structure, import rules, and prescription oversight in each priority market.

Research Methodology

This executive summary is based on a structured research approach combining secondary research, expert interpretation, and evidence triangulation. Sources include publicly available information from WOAH, FAO, WHO, FDA Center for Veterinary Medicine, EMA, USDA, Health Canada, European Commission veterinary medicine rules, VICH guidance, Codex residue standards, national animal health agencies, trade statistics, regulatory notices, and peer-reviewed literature.

The analysis applies cross-validation across regulatory signals, antimicrobial stewardship policies, disease trends, livestock and companion animal indicators, aquaculture development, manufacturing capacity, import-export patterns, quality requirements, and technology adoption. Qualitative insights are assessed against observable policy changes and documented industry practices to ensure conclusions remain evidence-led, commercially relevant, and suitable for executive decision-making without relying on market sizing, market share, or forecasting.

Conclusion and Strategic Outlook

The animal health active pharmaceutical ingredients market is entering a more disciplined growth phase defined by quality, transparency, regulatory alignment, antimicrobial stewardship, and supply reliability. Demand remains supported by animal protein production, companion animal health, aquaculture expansion, and the need to manage endemic and emerging animal diseases, but future competitiveness will depend on responsible use and documented product integrity.

Manufacturers and marketers that combine compliant production, robust pharmacovigilance, diversified sourcing, validated quality documentation, environmental controls, and AI-enabled operational intelligence will be best positioned to create resilient value. The strongest opportunities will emerge where animal welfare, food safety, disease prevention, residue compliance, antimicrobial resistance management, and secure animal health API supply chains converge.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Health Active Pharmaceutical Ingredients Market, by Product Type
7.1. Introduction
7.2. Anti Inflammatories APIs
7.3. Antibiotics APIs
7.4. Antiparasitics APIs
7.5. Hormonal & Reproductive APIs
7.6. Vaccines APIs
8. Animal Health Active Pharmaceutical Ingredients Market, by Animal Type
8.1. Introduction
8.2. Aquaculture
8.3. Companion Animals
8.4. Livestock
8.5. Poultry
9. Animal Health Active Pharmaceutical Ingredients Market, by Compound Type
9.1. Introduction
9.2. Biologic
9.3. Peptide
9.4. Small Molecule
10. Animal Health Active Pharmaceutical Ingredients Market, by Source
10.1. Introduction
10.2. Fermentation Derived
10.3. Natural Extracted
10.4. Synthetic
11. Animal Health Active Pharmaceutical Ingredients Market, by Physical Form
11.1. Introduction
11.2. Powder
11.3. Granules
11.4. Liquid
12. Animal Health Active Pharmaceutical Ingredients Market, by Route Of Administration
12.1. Introduction
12.2. Oral
12.3. Injectable
12.3.1. Subcutaneous
12.3.2. Intravenous
12.4. Topical
12.5. Intramammary
13. Animal Health Active Pharmaceutical Ingredients Market, by Application
13.1. Introduction
13.2. Infectious Disease Management
13.3. Pain Management
13.4. Parasitic Control
13.5. Immune Support
13.6. Reproductive Health
13.7. Chronic Disease Treatment
14. Animal Health Active Pharmaceutical Ingredients Market, by End-User
14.1. Introduction
14.2. Animal Feed Manufacturers
14.3. Pharmaceutical Companies
14.4. Contract Manufacturing Organizations (CMOs)
15. Animal Health Active Pharmaceutical Ingredients Market, by Region
15.1. Asia-Pacific
15.2. Europe
15.3. North America
15.4. Latin America
15.5. Africa
15.6. Middle East
16. Animal Health Active Pharmaceutical Ingredients Market, by Group
16.1. NATO
16.2. G7
16.3. BRICS
16.4. European Union
16.5. ASEAN
16.6. GCC
17. Animal Health Active Pharmaceutical Ingredients Market, by Country
17.1. China
17.2. United States
17.3. Japan
17.4. India
17.5. Germany
17.6. United Kingdom
17.7. Australia
17.8. France
17.9. South Korea
17.10. Italy
17.11. Canada
17.12. Russia
17.13. Brazil
17.14. Mexico
17.15. Spain
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. FPNV Positioning Matrix, 2025
18.3. Market Concentration Analysis, 2025
18.3.1. Concentration Ratio (CR)
18.3.2. Herfindahl Hirschman Index (HHI)
18.4. Recent Developments & Impact Analysis, 2025
18.5. Product Portfolio Analysis, 2025
18.6. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Abinopharm, Inc.
19.2. ACTIVET GmbH
19.3. Alivira Animal Health Limited
19.4. AMGIS Lifescience Ltd.
19.5. Ashish Life Science Pvt. Ltd.
19.6. Aurobindo Pharma Ltd.
19.7. Boehringer Ingelheim International GmbH
19.8. Cayman Pharma s.r.o.
19.9. Ceva Santé Animale
19.10. Chemo Holding, S.L.
19.11. Chr. Olesen Synthesis A/S
19.12. Cipla Ltd.
19.13. Elanco Animal Health Incorporated
19.14. Hikal Limited
19.15. Huvepharma Inc.
19.16. Hyasen Biotechnology Co., Ltd.
19.17. Karishma Pharma Pvt. Ltd.
19.18. Menon Animal Health
19.19. Merck & Co., Inc.
19.20. NGL Fine-Chem Ltd.
19.21. Phibro Animal Health Corporation
19.22. Ridgeway Biologicals Ltd.
19.23. Sequent Scientific Ltd.
19.24. Vetoquinol S.A.
19.25. Virbac SA
19.26. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 25. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 27. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 28. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 29. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ANTI INFLAMMATORIES APIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ANTI INFLAMMATORIES APIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ANTI INFLAMMATORIES APIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANTIBIOTICS APIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANTIBIOTICS APIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANTIBIOTICS APIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIPARASITICS APIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIPARASITICS APIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ANTIPARASITICS APIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL HORMONAL & REPRODUCTIVE APIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL HORMONAL & REPRODUCTIVE APIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL HORMONAL & REPRODUCTIVE APIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL VACCINES APIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL VACCINES APIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL VACCINES APIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL BIOLOGIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL BIOLOGIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL BIOLOGIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL PEPTIDE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL PEPTIDE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL PEPTIDE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SMALL MOLECULE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SMALL MOLECULE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SMALL MOLECULE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL FERMENTATION DERIVED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL FERMENTATION DERIVED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL FERMENTATION DERIVED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL NATURAL EXTRACTED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NATURAL EXTRACTED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NATURAL EXTRACTED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL POWDER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL POWDER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL POWDER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL GRANULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL GRANULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL GRANULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL LIQUID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL LIQUID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL LIQUID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL INJECTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL INJECTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL INJECTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SUBCUTANEOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SUBCUTANEOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL SUBCUTANEOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL INTRAVENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL INTRAVENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL INTRAVENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL INTRAMAMMARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL INTRAMAMMARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL INTRAMAMMARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL INFECTIOUS DISEASE MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL INFECTIOUS DISEASE MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL INFECTIOUS DISEASE MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL PAIN MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL PARASITIC CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL PARASITIC CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL PARASITIC CONTROL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL IMMUNE SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL IMMUNE SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL IMMUNE SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL REPRODUCTIVE HEALTH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL CHRONIC DISEASE TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL CHRONIC DISEASE TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CHRONIC DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL ANIMAL FEED MANUFACTURERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL ANIMAL FEED MANUFACTURERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL ANIMAL FEED MANUFACTURERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 121. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 123. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 124. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 125. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 126. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 127. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 128. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 129. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 130. EUROPE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. NORTH AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 151. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 153. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 154. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 155. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 156. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 157. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 158. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 159. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 160. AFRICA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 172. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 174. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 175. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 176. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 177. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 178. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 179. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 180. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. NATO ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 182. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 184. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 185. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 186. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 187. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 188. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 189. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 190. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. G7 ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 192. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 193. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 195. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 196. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 197. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 198. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 199. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 200. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. BRICS ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 202. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 203. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 204. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 205. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 206. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 212. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 213. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 214. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 215. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 216. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 217. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 218. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 219. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 220. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. ASEAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 222. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 223. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 224. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 225. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 226. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 227. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 228. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 229. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 230. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 231. GCC ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 232. GLOBAL ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 233. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 234. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 235. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 236. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 237. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 238. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 239. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 240. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 241. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 242. CHINA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 243. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 244. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 245. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 246. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 247. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 248. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 249. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 250. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 251. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. UNITED STATES ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 253. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 254. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 255. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 256. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 257. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 258. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 259. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 260. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 261. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. JAPAN ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 263. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 265. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 266. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 267. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 268. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 269. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 270. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 271. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. INDIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 273. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 274. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 275. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 276. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 277. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 278. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 279. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 280. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 281. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. GERMANY ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 283. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 284. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 285. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 286. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 287. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 288. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 289. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 290. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 291. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. UNITED KINGDOM ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 293. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 294. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 295. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ANIMAL TYPE, 2017-2032 (USD MILLION)
TABLE 296. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COMPOUND TYPE, 2017-2032 (USD MILLION)
TABLE 297. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY SOURCE, 2017-2032 (USD MILLION)
TABLE 298. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PHYSICAL FORM, 2017-2032 (USD MILLION)
TABLE 299. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 300. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY INJECTABLE, 2017-2032 (USD MILLION)
TABLE 301. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 302. AUSTRALIA ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY END-USER, 2017-2032 (USD MILLION)
TABLE 303. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 304. FRANCE ANIMAL HEALTH ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 305. FRANCE ANIMAL HEALTH

Companies Mentioned

  • Abinopharm, Inc.
  • ACTIVET GmbH
  • Alivira Animal Health Limited
  • AMGIS Lifescience Ltd.
  • Ashish Life Science Pvt. Ltd.
  • Aurobindo Pharma Ltd.
  • Boehringer Ingelheim International GmbH
  • Cayman Pharma s.r.o.
  • Ceva Santé Animale
  • Chemo Holding, S.L.
  • Chr. Olesen Synthesis A/S
  • Cipla Ltd.
  • Elanco Animal Health Incorporated
  • Hikal Limited
  • Huvepharma Inc.
  • Hyasen Biotechnology Co., Ltd.
  • Karishma Pharma Pvt. Ltd.
  • Menon Animal Health
  • Merck & Co., Inc.
  • NGL Fine-Chem Ltd.
  • Phibro Animal Health Corporation
  • Ridgeway Biologicals Ltd.
  • Sequent Scientific Ltd.
  • Vetoquinol S.A.
  • Virbac SA
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 10.87 Billion
Forecasted Market Value ( USD ) by 2032 $ 15.73 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Active Pharmaceutical Ingredients Market (API) - Global Forecast 2026-2032 - Product Image

Active Pharmaceutical Ingredients Market (API) - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Veterinary API Market Size, Share & Trends Analysis Report by Animal (Production, Companion), Service (in House, Contract Outsourcing), Synthesis (Chemical Based API, Biological API, HPAPI), Therapeutic Category, and Region with Growth Forecasts, 2026-2033 - Product Image

Veterinary API Market Size, Share & Trends Analysis Report by Animal (Production, Companion), Service (in House, Contract Outsourcing), Synthesis (Chemical Based API, Biological API, HPAPI), Therapeutic Category, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Veterinary Active Pharmaceutical Ingredients Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 180 Pages
  • Global
From
Companion Animal Health Market - Global Forecast 2026-2032 - Product Image

Companion Animal Health Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Veterinary Active Pharmaceutical Ingredients Manufacturing - Global Strategic Business Report - Product Image

Veterinary Active Pharmaceutical Ingredients Manufacturing - Global Strategic Business Report

  • Report
  • 458 Pages
  • Global
From

About the Animal Health Active Pharmaceutical Ingredients Market

The Animal Health Active Pharmaceutical Ingredients (API) market is a segment of the animal pharmaceuticals industry. It is composed of active ingredients used in the production of animal health products, such as vaccines, antibiotics, and other drugs. These APIs are used to treat a variety of animal diseases, including those caused by bacteria, viruses, and parasites. The market is driven by the increasing demand for animal health products, as well as the growing awareness of animal welfare. The market is highly competitive, with a number of large and small companies operating in the space. Companies in the market include Zoetis, Merck Animal Health, Elanco Animal Health, Bayer Animal Health, and Boehringer Ingelheim Animal Health. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.